David Graham Tew

Title: **David Graham Tew: Innovator in Atherosclerosis Treatment**

Introduction

David Graham Tew is an accomplished inventor based in Audubon, Pennsylvania. He has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative treatments for cardiovascular diseases. With 2 patents to his name, Tew is recognized for his pioneering work in the pharmaceutical industry.

Latest Patents

David Graham Tew's latest patents focus on azetidinone derivatives for the treatment of atherosclerosis. His patents include:

1. **Azetidinone derivatives for the treatment of atherosclerosis**

2. **Substituted azetidin-2-ones for treatment of atherosclerosis**

These inventions are intended to address critical health issues associated with atherosclerosis, potentially offering new avenues for treatment.

Career Highlights

Tew works at SmithKline Beecham Corporation, a leading global healthcare company where he has contributed his expertise in drug development. His role at the corporation underscores his commitment to advancing health care through innovative research and development in the pharmaceutical field.

Collaborations

Throughout his career, David Graham Tew has collaborated with talented colleagues, including Deirdre M Hickey and Dashyant Dhanak. These partnerships highlight the collaborative nature of pharmaceutical research, where innovative ideas emerge from shared knowledge and expertise.

Conclusion

David Graham Tew stands out as a key figure in the development of treatments for atherosclerosis. His work exemplifies the spirit of innovation and the importance of collaboration in the medical field. With his ongoing contributions at SmithKline Beecham Corporation, Tew continues to play an essential role in the fight against cardiovascular diseases.